• Blog
  • Automated External Defibrillators Market Report

    Automated External Defibrillators Market Report

    Automated External Defibrillators Market Report
    Report code - SRHL217 Delivery - 2 Weeks
    Get Free Sample |
    Play Audio
    Listen
    Global Automated External Defibrillators Market, Dynamics, Market Analysis
    See more...

    Impact of COVID-19 on Automated External Defibrillators Market

    Covid-19 has impacted the market dynamics, competition, and global...

    See more...

    Impact of COVID-19 on Automated External Defibrillators Market

    Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.

    Note: The summary below might not have included insights on covid impact since we have large number of reports.

    Market Insights

    The Global Automated External Defibrillators Market is estimated to grow from USD 1.6 billion in 2020 to USD 2.4 billion by 2026 at a healthy CAGR of 7.1% during the forecast period.

    Figure: Global Automated External Defibrillators Market Size, 2020-2026 (USD Billion)

    Automated-External-Defibrillators-Market-Forecast

    To get a sample report, Click here…

    What are Automated external defibrillators?

    Automated external defibrillators are defined as portable, life-saving devices which analyze the rhythm of the heart and treat people who experience sudden cardiac arrest. Cardiac arrest is a medical ailment wherein the heart stops beating. This device detects the problem and treats the same by delivering an electric shock to restore normal heart rhythm. These devices are of small size and thus, are easy to use.

    Key Players

    Key players operating in the global Automated External Defibrillators market are-

    • Koninklijke Philips N.V. (Netherlands),
    • Physio-Control Corporation (The U.S),
    • Asahi Kasei Medical Co., Ltd (Japan),
    • Nihon Kohden Corporation (Japan),
    • Schiller AG (Switzerland),
    • Mindray Medical International Limited (China),
    • GE Healthcare (The U.S),
    • Stryker Corporation (The U.S),
    • Cardiac Science Corporation (The U.S),
    • Zoll Medical Corporation (The U.S),
    • Me­trax GmbH (Germany), and
    • Biotronik (Germany).

    Market Dynamics

    The rapidly expanding aging population has also resulted in increased demands for automated external defibrillators.

    • The global market growth is primarily driven by an increase in the number of people suffering from cardiovascular diseases as a result of a busy lifestyle and unhealthy eating habits.
    • The rise in the number of people dying due to cardiac arrest is likely to fuel the demand for automated defibrillators at a significant rate.
    • Growing emphasis on technological advancement in these devices is expected to create lucrative opportunities for the players operating in the global automated external defibrillators market during the review period.

    Segment Analysis

    End User Trends

    Based on end user, the market has been divided into hospitals, public access, emergency medical services, homes, and private cardiac clinics.

    In 2020, the hospitals segment garnered the largest market share. The public access segment is likely to grow at a significant rate during the review period on account of rise in number of sudden cardiac arrest cases worldwide.

    Regional Trends

    The market in North America accounted for largest share of approximately 30% in 2020.

    This was due to increasing geriatric population, rise in number of people dying due to cardiac arrest and growing emphasis on technological advancement in defibrillators.

    The market in Asia-Pacific region is projected to register healthy growth rate on account of rising product awareness among consumers and expanding healthcare industry in the developing countries.

    COVID-19 Impact on Global Automated External Defibrillators Market

    The Covid-19 outbreak impacted the growth of the automated external defibrillators positively. With the rapid surge in covid-19 cases, the healthcare facilities across geographies were focusing on treating patients infected with coronavirus. This resulted in increased need for automated defibrillators to ensure patients suffering from cardiac arrest could be provided with best chances of survival.

    Get the full scope of the report. Register Here

    Critical questions answered in this report -

    • What are the key trends in the global automated external defibrillators market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in next five years?
    • What is the impact of COVID-19 on global automated external defibrillators market?
    • What are the key strategies adopted by the major vendors to lead in the global automated external defibrillators market?
    • What is the market share of the top vendors?

    Target Audience

    The following is a list of the customers that the global automated external defibrillators market aims to convert the most:

    • Automated external defibrillators distributors
    • Automated external defibrillators suppliers
    • Automated external defibrillators manufacturers
    • Logistics organizations
    • Government Bodies

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].

    Frequently Asked Questions (FAQs)

    The automated external defibrillators market is expected to grow at a CAGR of 7.1% in the foreseeable future.

    Koninklijke Philips N.V. (Netherlands), Physio-Control Corporation (The U.S), Asahi Kasei Medical Co., Ltd (Japan), Nihon Kohden Corporation (Japan), Schiller AG (Switzerland), Mindray Medical International Limited (China), GE Healthcare (The U.S), Stryker Corporation (The U.S), Cardiac Science Corporation (The U.S), Zoll Medical Corporation (The U.S), Metrax GmbH (Germany), and Biotronik (Germany) are among the key players in the automated external defibrillators market.

    The automated external defibrillators market is expected to reach USD 2.4 billion in the coming years.

    North America accounted for the largest share of the automated external defibrillators market in 2020.

    The hospitals segment garnered the largest share of automated external defibrillators market in 2020.

    The rapidly expanding aging population, increase in the number of people suffering from cardiovascular diseases, rise in the number of people dying due to cardiac arrest, growing emphasis on technological advancement are the factors driving the growth of automated external defibrillators market.

    Automated external defibrillators distributors, Automated external defibrillators suppliers, Automated external defibrillators manufacturers, Logistics organizations, Government Bodies are the target audience in the automated external defibrillators market.

    •